Sandbox Reserved 1123: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Loïc Duffet (talk | contribs) No edit summary |
Loïc Duffet (talk | contribs) No edit summary |
||
| Line 36: | Line 36: | ||
<Structure load='2XDE' size='400' frame='false' align='left' caption='Cristal structure of PF-3450074 with N terminal domain of HIV capsid PDB:2XDE' scene='71/719864/Hiv_dimer_with_ligand/1' />' | <Structure load='2XDE' size='400' frame='false' align='left' caption='Cristal structure of PF-3450074 with N terminal domain of HIV capsid PDB:2XDE' scene='71/719864/Hiv_dimer_with_ligand/1' />' | ||
Thank to its central role in viral infectious process (genome protection, enveloppe cohesion, uncoating, budding), HIV capsid is a very good target for antiviral drugs. As a result, many research teams are working in this way and some molecules such as PF-3450074 <ref name="A"/> are very promising. | Thank to its central role in viral infectious process (genome protection, enveloppe cohesion, uncoating, budding), HIV capsid is a very good target for antiviral drugs. As a result, many research teams are working in this way and some molecules such as <scene name='71/719864/Pf-3450074_ligand/2'>PF-3450074</scene> <ref name="A"/> are very promising. | ||
By binding to a "central pocket" on P24, it was shown ''in vitro'' that this compound is inhibiting the new viruses assembly, and consequently the virus budding. | By binding to a "central pocket" on P24, it was shown ''in vitro'' that this compound is inhibiting the new viruses assembly, and consequently the virus budding. | ||
